Bukit Uluwatu Villa Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp725 (market cap 18.59T, 72.39M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 39.5× Prodia Diagnostic Line Tbk's market cap, and Bukit Uluwatu Villa Tbk is more actively traded (72.39M versus 28.43M). Which is the better fit depends on your goals.
| BUVA | PRDL | |
|---|---|---|
Market Cap | 18.59T | 470.58B |
Volume | 72.39M | 28.43M |
Lot | 723.87K | 284.34K |
Turnover | 53.33B | 7.8B |
Average Price | 736.69 | 274.19 |
Value | 53.33B | 7.8B |
Indicative Equilibrium Price | 725 | 270 |
Indicative Equilibrium Volume | 12.22K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).
Read more on BUVA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →